VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Sales update soon?

<< Previous

Bullboard Posts

Next >>

Comment by WalkOverTheStrton Nov 18, 2023 12:39pm

82 Views

Post# 35742636

RE:RE:RE:RE:RE:RE:RE:RE:RE:Sales update soon?

Like the enthusiam but no company wants to take the chance of running out of capital even with a potential revenue stream going online in the near term (Ascend). I expect a raise as even if Ascend launched tomorrow it will take months minimum to build up adoption, it isnt a light switch. Even with VMS on Ascend's platform someone (Ascend/VMS) has to sell/educate the end users on VMS. That takes time.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale